These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 16773214
21. [Anti-Yo antibody associated paraneoplastic cerebellar degeneration with gastric adenocarcinoma in a male patient: a case report]. Goto A, Kusumi M, Wakutani Y, Nakaso K, Kowa H, Nakashima K. Rinsho Shinkeigaku; 2006 Feb; 46(2):144-7. PubMed ID: 16619840 [Abstract] [Full Text] [Related]
22. The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease. Greenlee JE, Brashear HR. Cerebellum; 2023 Aug; 22(4):531-533. PubMed ID: 35881322 [Abstract] [Full Text] [Related]
23. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody]. Tremouilhac C, Hamy A, De Ferron E, Paineau J, Visset J. J Gynecol Obstet Biol Reprod (Paris); 1996 Aug; 25(3):253-6. PubMed ID: 8767221 [Abstract] [Full Text] [Related]
31. [Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report]. Kawanishi K, Morita M, Nakahara K, Tetsuka S, Kouki T, Tominaga K, Endo H, Yashiro T, Tanaka K, Nakano I. Brain Nerve; 2013 Nov; 65(11):1401-5. PubMed ID: 24200618 [Abstract] [Full Text] [Related]
32. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature. Cao Y, Abbas J, Wu X, Dooley J, van Amburg AL. Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450 [Abstract] [Full Text] [Related]
33. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications. Yshii L, Bost C, Liblau R. Front Immunol; 2020 Oct; 11():991. PubMed ID: 32655545 [Abstract] [Full Text] [Related]
34. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma. Bruhnding A, Notch D, Beard A. J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258 [Abstract] [Full Text] [Related]
37. IFN-γ is a therapeutic target in paraneoplastic cerebellar degeneration. Yshii L, Pignolet B, Mauré E, Pierau M, Brunner-Weinzierl M, Hartley O, Bauer J, Liblau R. JCI Insight; 2019 Apr 04; 4(7):. PubMed ID: 30944244 [Abstract] [Full Text] [Related]
40. A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers. Landtblom AM, Lindvall B, Ledin T, Berlin G. Ther Apher Dial; 2008 Feb 04; 12(1):82-5. PubMed ID: 18257818 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]